1. Home
  2. RZLT vs UPBD Comparison

RZLT vs UPBD Comparison

Compare RZLT & UPBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RZLT
  • UPBD
  • Stock Information
  • Founded
  • RZLT 2010
  • UPBD 1986
  • Country
  • RZLT United States
  • UPBD United States
  • Employees
  • RZLT N/A
  • UPBD N/A
  • Industry
  • RZLT Biotechnology: Pharmaceutical Preparations
  • UPBD Diversified Commercial Services
  • Sector
  • RZLT Health Care
  • UPBD Consumer Discretionary
  • Exchange
  • RZLT Nasdaq
  • UPBD Nasdaq
  • Market Cap
  • RZLT 997.7M
  • UPBD 1.0B
  • IPO Year
  • RZLT N/A
  • UPBD 1995
  • Fundamental
  • Price
  • RZLT $9.57
  • UPBD $18.48
  • Analyst Decision
  • RZLT Strong Buy
  • UPBD Strong Buy
  • Analyst Count
  • RZLT 6
  • UPBD 4
  • Target Price
  • RZLT $15.33
  • UPBD $32.50
  • AVG Volume (30 Days)
  • RZLT 1.5M
  • UPBD 962.8K
  • Earning Date
  • RZLT 11-06-2025
  • UPBD 10-30-2025
  • Dividend Yield
  • RZLT N/A
  • UPBD 8.54%
  • EPS Growth
  • RZLT N/A
  • UPBD N/A
  • EPS
  • RZLT N/A
  • UPBD 1.45
  • Revenue
  • RZLT N/A
  • UPBD $4,577,844,000.00
  • Revenue This Year
  • RZLT N/A
  • UPBD $10.26
  • Revenue Next Year
  • RZLT N/A
  • UPBD $7.68
  • P/E Ratio
  • RZLT N/A
  • UPBD $12.58
  • Revenue Growth
  • RZLT N/A
  • UPBD 7.48
  • 52 Week Low
  • RZLT $2.22
  • UPBD $15.82
  • 52 Week High
  • RZLT $11.46
  • UPBD $35.12
  • Technical
  • Relative Strength Index (RSI)
  • RZLT 49.79
  • UPBD 46.92
  • Support Level
  • RZLT $9.34
  • UPBD $15.82
  • Resistance Level
  • RZLT $10.03
  • UPBD $18.61
  • Average True Range (ATR)
  • RZLT 0.77
  • UPBD 0.68
  • MACD
  • RZLT -0.09
  • UPBD 0.29
  • Stochastic Oscillator
  • RZLT 16.25
  • UPBD 92.76

About RZLT Rezolute Inc. (NV)

Rezolute Inc is a clinical-stage biopharmaceutical company focused on developing therapies for rare and metabolic diseases. The company aims to address unmet medical needs in conditions like congenital hyperinsulinism, a rare endocrine disorder causing excessive insulin production and resulting hypoglycemia. Rezolute's pipeline includes drug candidates designed to improve patient outcomes while reducing treatment burdens. The company engages in research, development, and clinical trials to advance its therapies and collaborates with medical communities and patient groups to support its objectives. Revenue and value creation depend largely on successful product development and regulatory approvals.

About UPBD Upbound Group Inc.

Upbound Group Inc is an omnichannel platform company committed to elevating financial opportunity for all through inclusive, and technology-driven financial solutions that address the evolving needs and aspirations of consumers. It has three operating segments; The Rent-A-Center Business segment operates lease-to-own stores, the Acima segment offers the lease-to-own transaction to consumers who do not qualify for financing from the traditional retailer, and also offers the lease-to-own transaction through virtual offering solutions across e-commerce, digital, and mobile channels, Mexico segment offers lease-to-own stores in Mexico. The franchising segment offers the sale of rental merchandise to its franchisees. The company derives a majority of its revenue from the Acima segment.

Share on Social Networks: